These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 39231247)
1. Serum steroid profiling in the diagnosis of adrenocortical carcinoma: a prospective cohort study. Yu K; Athimulam S; Saini J; Kaur RJ; Xue Q; McKenzie TJ; Singh RJ; Grebe S; Bancos I J Clin Endocrinol Metab; 2024 Sep; ():. PubMed ID: 39231247 [TBL] [Abstract][Full Text] [Related]
2. Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma. Weng Y; Tang JY; Zhang XY; Lin DZ; Guo Y; Liang Y; Wang L; Zhou J; Yan L; Lin TX; Zhang SL Front Endocrinol (Lausanne); 2024; 15():1435102. PubMed ID: 39359414 [TBL] [Abstract][Full Text] [Related]
3. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma. Schweitzer S; Kunz M; Kurlbaum M; Vey J; Kendl S; Deutschbein T; Hahner S; Fassnacht M; Dandekar T; Kroiss M Eur J Endocrinol; 2019 Feb; 180(2):117-125. PubMed ID: 30481155 [TBL] [Abstract][Full Text] [Related]
4. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Bancos I; Taylor AE; Chortis V; Sitch AJ; Jenkinson C; Davidge-Pitts CJ; Lang K; Tsagarakis S; Macech M; Riester A; Deutschbein T; Pupovac ID; Kienitz T; Prete A; Papathomas TG; Gilligan LC; Bancos C; Reimondo G; Haissaguerre M; Marina L; Grytaas MA; Sajwani A; Langton K; Ivison HE; Shackleton CHL; Erickson D; Asia M; Palimeri S; Kondracka A; Spyroglou A; Ronchi CL; Simunov B; Delivanis DA; Sutcliffe RP; Tsirou I; Bednarczuk T; Reincke M; Burger-Stritt S; Feelders RA; Canu L; Haak HR; Eisenhofer G; Dennedy MC; Ueland GA; Ivovic M; Tabarin A; Terzolo M; Quinkler M; Kastelan D; Fassnacht M; Beuschlein F; Ambroziak U; Vassiliadi DA; O'Reilly MW; Young WF; Biehl M; Deeks JJ; Arlt W; Lancet Diabetes Endocrinol; 2020 Sep; 8(9):773-781. PubMed ID: 32711725 [TBL] [Abstract][Full Text] [Related]
5. A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma. Taylor DR; Ghataore L; Couchman L; Vincent RP; Whitelaw B; Lewis D; Diaz-Cano S; Galata G; Schulte KM; Aylwin S; Taylor NF Clin Chem; 2017 Dec; 63(12):1836-1846. PubMed ID: 28904054 [TBL] [Abstract][Full Text] [Related]
6. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861 [TBL] [Abstract][Full Text] [Related]
7. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors. Vogg N; Müller T; Floren A; Dandekar T; Riester A; Dischinger U; Kurlbaum M; Kroiss M; Fassnacht M Clin Chim Acta; 2023 Mar; 543():117301. PubMed ID: 36948238 [TBL] [Abstract][Full Text] [Related]
8. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas. Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174 [TBL] [Abstract][Full Text] [Related]
9. Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma. Suzuki S; Minamidate T; Shiga A; Ruike Y; Ishiwata K; Naito K; Ishida A; Deguchi H; Fujimoto M; Koide H; Tatsuno I; Ikeda JI; Yamazaki Y; Sasano H; Yokote K BMC Endocr Disord; 2020 Nov; 20(1):173. PubMed ID: 33228607 [TBL] [Abstract][Full Text] [Related]
10. High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders. Hines JM; Bancos I; Bancos C; Singh RD; Avula AV; Young WF; Grebe SK; Singh RJ Clin Chem; 2017 Dec; 63(12):1824-1835. PubMed ID: 28814383 [TBL] [Abstract][Full Text] [Related]
11. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma. Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449 [TBL] [Abstract][Full Text] [Related]
12. The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors. Chortis V Minerva Endocrinol; 2019 Mar; 44(1):19-24. PubMed ID: 29905434 [TBL] [Abstract][Full Text] [Related]
13. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Romero Arenas MA; Whitsett TG; Aronova A; Henderson SA; LoBello J; Habra MA; Grubbs EG; Lee JE; Sircar K; Zarnegar R; Scognamiglio T; Fahey TJ; Perrier ND; Demeure MJ Ann Surg Oncol; 2018 Mar; 25(3):801-807. PubMed ID: 29218429 [TBL] [Abstract][Full Text] [Related]
14. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma. Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854 [TBL] [Abstract][Full Text] [Related]
15. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone. Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Role of Prostate-Specific Membrane Antigen in Adrenocortical Carcinoma. Gu Y; Gu W; Dou J; Lu Z; Ba J; Li J; Wang X; Liu H; Yang G; Guo Q; Zang L; Chen K; Du J; Pei Y; Mu Y Front Endocrinol (Lausanne); 2019; 10():226. PubMed ID: 31040822 [No Abstract] [Full Text] [Related]
17. Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry. Petersenn S; Richter PA; Broemel T; Ritter CO; Deutschbein T; Beil FU; Allolio B; Fassnacht M; Eur J Endocrinol; 2015 Apr; 172(4):415-22. PubMed ID: 25599706 [TBL] [Abstract][Full Text] [Related]
18. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Soon PS; Libe R; Benn DE; Gill A; Shaw J; Sywak MS; Groussin L; Bertagna X; Gicquel C; Bertherat J; McDonald KL; Sidhu SB; Robinson BG Ann Surg; 2008 Jan; 247(1):157-64. PubMed ID: 18156936 [TBL] [Abstract][Full Text] [Related]
20. A case of adrenocortical carcinoma diagnosed 9 years after the discovery of adrenal incidentaloma. Aono D; Kometani M; Asano T; Konishi S; Karashima S; Ikeda H; Nohara T; Yoneda T Endocr J; 2022 Dec; 69(12):1415-1421. PubMed ID: 35934796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]